Correction: Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor

Documenti analoghi

• Tumor driven by gain-of-function HER2 H878Y mutant is highly sensitive to HER2 inhibitor
  di: Hu, Zexi, et al.
  Pubblicazione: (2015)
• Phosphorylation of Mutationally Introduced Tyrosine in the Activation Loop of HER2 Confers Gain-of-Function Activity
  di: Hu, Zexi, et al.
  Pubblicazione: (2015)
• Mutant p53 gain of function induces HER2 over-expression in cancer cells
  di: Román-Rosales, A. A., et al.
  Pubblicazione: (2018)
• Mutant PIK3CA accelerates HER2-driven transgenic mammary tumors and induces resistance to combinations of anti-HER2 therapies
  di: Hanker, Ariella B., et al.
  Pubblicazione: (2013)
• An acquired HER2 T798I gatekeeper mutation induces resistance to neratinib in a patient with HER2 mutant-driven breast cancer
  di: Hanker, Ariella B., et al.
  Pubblicazione: (2017)